Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin and Dickkopf-1 Levels of Naive Postmenopausal Women With Low Bone Mass: A Randomized, Head-to-Head Clinical Trial | Zendy

Athanasios D. Anastasilakis | Zendy; Stergios A. Pοlyzos | Zendy; Athina Gkiomisi | Zendy; Ilias Bisbinas | Zendy; Spyridon Gerou | Zendy; Polyzois Makras | Zendy

Open Access

Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin and Dickkopf-1 Levels of Naive Postmenopausal Women With Low Bone Mass: A Randomized, Head-to-Head Clinical Trial

Author(s) -

Athanasios D. Anastasilakis,

Stergios A. Pοlyzos,

Athina Gkiomisi,

Ilias Bisbinas,

Spyridon Gerou,

Polyzois Makras

Publication year - 2013

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2013-1402

Subject(s) - sclerostin , zoledronic acid , n terminal telopeptide , medicine , endocrinology , osteoprotegerin , bone resorption , denosumab , bone remodeling , osteoporosis , osteocalcin , chemistry , activator (genetics) , receptor , alkaline phosphatase , wnt signaling pathway , biochemistry , gene , enzyme

Decreased bone formation due to a coupling effect limits bone mass increases after antiresorptive treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research